510(k) K250930

twiist system by Deka Research & Development Corp. — Product Code QFG

K250930 is an FDA 510(k) premarket notification submitted by Deka Research & Development Corp. for the device "twiist system". The FDA issued a decision of Substantially Equivalent on Apr 2, 2025. The device falls under product code QFG (Alternate Controller Enabled Insulin Infusion Pump), a Class II device regulated under 21 CFR 880.5730. Deka Research & Development Corp. has 27 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Apr 2, 2025
Date Received
Mar 28, 2025
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Alternate Controller Enabled Insulin Infusion Pump
Device Class
Class II
Regulation Number
880.5730
Review Panel
CH
Submission Type
510(k)

An alternate controller enabled insulin infusion pump (ACE insulin pump) is a device intended for the infusion of insulin into a patient. The ACE insulin pump may include basal and bolus drug delivery at set or variable rates. ACE insulin pumps are designed to reliably and securely communicate with external devices, such as automated insulin dosing systems, to allow insulin delivery commands to be received, executed, and confirmed. ACE insulin pumps are intended to be used both alone and in conjunction with digitally connected medical devices for the purpose of insulin delivery.

Need the full FDA record for Deka Research & Development Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K250930. Report a data issue: hello@regdatalab.com.